 |
"In
a letter to the drugmaker, the FDA said the agency approved Beyfortus,
an RSV monoclonal antibody, as a defense against RSV lower respiratory
tract disease — but that Sanofi has been claiming it protects broadly
against RSV disease, which occurs in the lower and upper tracts.
Beyfortus has come under scrutiny following reports of at least two
infant deaths during clinical trials for the drug." https://www.fiercepharma.com/marketing/fda-untitled-letter-calls-out-sanofi |
Monday, July 27, 2026
Sanofi made False Claims about RSV Shot for Infants FDA says
Sunday, July 26, 2026
PIZZA FOR CV VX INJURY
PIZZA FOR CV VX INJURY - Maribel Duarte says her CV VX-injured 13-year-old son Moises, who is a student at Barack Obama Global Preparation Academy, was offered a piece of pizza for receiving the CV VX in December 2021. And not only was he vaccinated without her consent, Moises was made to forge her name on a consent form. The case was settled out of court.
California Senate Bill 866 (2022), which would have allowed children aged 12 and older to consent to vaccinations without parental consent, did not pass. The bill was withdrawn in 2022
Friday, July 24, 2026
Indian Government’s HPV Vaccine Campaign Is Target of Legal Challenge
A
high court in India will consider a legal challenge to the national
rollout of the human papillomavirus (HPV) vaccination program for
adolescent girls using Merck’s Gardasil 4 vaccine, The Indian Express reported.
The
Delhi High Court on Wednesday agreed to consider a Public Interest
Litigation brought by multiple parties concerned about deaths that
occurred during clinical trials for the HPV vaccine in the Indian states
of Gujarat and Andhra Pradesh. The deaths were reported in 2010.
👀 Full Story Here
Subscribe to:
Posts (Atom)